Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
3.1. Market Snippet by Product Type
3.2. Market Snippet by Component
3.3. Market Snippet by Application
3.4. Market Snippet by End-User
3.5. Market Snippet by Region
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Technological Advancements
4.1.1.2. Rising of Biopharmaceutical Industry
4.1.1.3. XX
4.1.2. Restraints:
4.1.2.1. Regulatory, scientific, and ethical challenges
4.1.2.2. Risk associated with use of Recombinant DNA Technology
4.1.2.3. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Epidemiology
5.3. Pipeline Analysis
5.4. Supply Chain Analysis
5.5. Pricing Analysis
5.6. Regulatory Analysis
5.7. Reimbursement Analysis
5.8. Unmet Needs
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
7.3. Market Attractiveness Index, By Product Type Segment
7.3.1. Medical*
7.3.1.1. Introduction
7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
7.3.1.3. Therapeutic Agent
7.3.1.4. Human Protein
7.3.1.5. Vaccine
7.3.2. Non-medical
7.3.2.1. Biotech Crops
7.3.2.2. Specialty Chemicals
7.3.2.3. Other
8. By Component
8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
8.3. Market Attractiveness Index, By Component Segment
8.3.1. Expression System*
8.3.1.1. Introduction
8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
8.3.1.3. Mammalian
8.3.1.4. Bacteria
8.3.1.5. Yeast
8.3.1.6. Baculovirus / Insect
8.3.1.7. Others
8.3.2. Cloning Vector
9. By Application
9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.3. Market Attractiveness Index, By Application Segment
9.3.1. Food and Agriculture*
9.3.1.1. Introduction
9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
9.3.2. Health and Disease
9.3.3. Environment
9.3.4. Others
10. By End-User
10.1. Introduction
10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
10.3. Market Attractiveness Index, By End-User Segment
10.3.1. Biotechnology and Pharmaceutical Companies*
10.3.1.1. Introduction
10.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
10.3.2. Academic and Government Research Institutes
10.3.3. Others
11. By Region
11.1. Introduction
11.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
11.3. Market Attractiveness Index, By Region
11.4. North America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. U.S.
11.4.7.2. Canada
11.4.7.3. Mexico
11.5. Europe
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. Germany
11.5.7.2. U.K.
11.5.7.3. France
11.5.7.4. Italy
11.5.7.5. Spain
11.5.7.6. Rest of Europe
11.6. South America
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
11.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.6.7.1. Brazil
11.6.7.2. Argentina
11.6.7.3. Rest of South America
11.7. Asia Pacific
11.7.1. Introduction
11.7.2. Key Region-Specific Dynamics
11.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
11.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
11.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.7.7.1. China
11.7.7.2. India
11.7.7.3. Japan
11.7.7.4. Australia
11.7.7.5. Rest of Asia Pacific
11.8. Middle East and Africa
11.8.1. Introduction
11.8.2. Key Region-Specific Dynamics
11.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
11.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Monsanto Company*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. F. Hoffmann-La Roche Ltd
13.3. Biogen
13.4. Amgen Inc
13.5. Novartis AG
13.6. Eli Lilly and Company
13.7. GenScript
13.8. Pfizer Inc.
13.9. Novo Nordisk A/S
13.10. Sanofi
13.11. Merck KGaA
13.12. Profacgen
13.13. Biocon
13.14. GlaxoSmithKline plc.
13.15. Cibus
13.16. Horizon Discovery Group plc
13.17. New England Biolabs
13.18. Thermo Fisher Scientific, Inc. (LIST NOT EXHAUSTIVE)
14. DataM Intelligence
14.1. Appendix
14.2. About Us and Services
14.3. Contact Us